Skip To Content

Sharing perspectives leads to greater understanding and fuels innovation.

The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.

January 14, 2021 · Policy Matters team
Listed below are brief updates on several recent policy developments across the country. Read more...
January 06, 2021 · Settlement Solutions Team
To help our clients achieve the lowest possible Workers’ Compensation Medicare Set-Aside (WCMSA) allocations, Optum continually monitors the average wholesale price (AWP) of the most common medications seen in a WCMSA. The following outlines the most recent price decreases for a few of these medications. Read more...
December 21, 2020 · Lavonya Chapman, Associate General Counsel of Optum Settlement Solutions
The recently enacted Provide Accurate Information Directly (PAID) Act will make it easier to determine whether payments for claimed injuries/illness involving workers’ compensation, no-fault and/or liability claims were made by traditional Medicare and/or a Medicare Advantage (Part C) plan (MAP) and/or a prescription Part D plan (PDP) and whether they need to be reimbursed. Read more...
December 15, 2020 · Policy Matters team
Listed below are brief updates on several recent policy developments across the country. Read more...
December 07, 2020 · Lavonya Chapman, Esq, RN, CMSP, Associate General Counsel, Optum Settlement Solutions
On November 12, 2020, the Centers for Medicare and Medicaid Services (CMS) issued a Technical Alert and published version 6.1 of the Non-Group Health Plan (NGHP) Section 111 User Guide. Both note changes that will eventually impact Civil Money Penalties (CMP) involving Section 111 reporting when CMS error tolerance thresholds are exceeded. Read more...
November 24, 2020 · Clinical Team
The U.S. Food and Drug Administration (FDA) authorized the use of the Lucira™ COVID-19 All-In-One Test Kit under an Emergency Use Authorization (EUA) on November 17, 2020.  This is the first at-home nasal swab test kit to detect SARS-CoV-2  the virus that causes the coronavirus disease 2019 (COVID-19). Read more...
November 23, 2020 · Policy Matters team
Listed below are brief updates on several recent policy developments across the country. Read more...
November 18, 2020 · Public Policy & Regulatory Affairs Team
The New York Workers’ Compensation Board (WCB) has temporarily suspended application of drug formulary refill/renewal requirements, moving them from January 1, 2021, to an undetermined date at this time. Read more...
     Next >>
Page 1 of 14

Subscribe today to receive our latest blogs, articles and more.